Article Text
Editorial
Anti-IL-1 agents: a paradigm shift in medical therapy for recurrent pericarditis?
Statistics from Altmetric.com
Footnotes
Contributors MI confirmed that the paper is original and approved for submission. MI is the sole author of this editorial.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests MI has been advisory board member for Sobi and Kiniksa.
Patient and public involvement Patients and/or the public were not involved in the design, conduct, reporting or dissemination plans of this research.
Patient consent for publication Not required.
Linked Articles
- Heart failure and cardiomyopathies